24 Einträge gefunden

1. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.

   1. Schulze, Friedrich
   2. Carter, Angela M
   3. Schwedhelm, Edzard
   4. Ajjan, Ramzi
   5. Maas, Renke
   6. von Holten, Rouven-Alexander
   7. Atzler, Dorothee

   2010 - Forschungsinformationssystem des UKE
2. Association of plasma ADMA levels with MRI markers of vascular brain injury: Framingham offspring study.

   1. Pikula, Aleksandra
   2. Böger, Rainer
   3. Beiser, Alexa S
   4. Maas, Renke
   5. DeCarli, Charles
   6. Schwedhelm, Edzard
   7. Himali, Jayandra J

   2009 - Forschungsinformationssystem des UKE
3. Asymmetric dimethylarginine predicts outcome and time of stay in hospital in patients attending an internal medicine emergency room.

   1. Schulze, Friedrich
   2. Vollert, Jörn
   3. Maas, Renke
   4. Müller, Reinhold
   5. Schwedhelm, Edzard
   6. Müller, Christian
   7. Böger, Rainer

   2009 - Forschungsinformationssystem des UKE
4. Plasma asymmetric dimethylarginine, L-arginine and left ventricular structure and function in a community-based sample.

   1. Lieb, Wolfgang
   2. Benndorf, Ralf
   3. Benjamin, Emelia J
   4. Sullivan Lisa, M
   5. Maas, Renke
   6. Xanthakis, Vanessa
   7. Schwedhelm, Edzard

   2009 - Forschungsinformationssystem des UKE
5. Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality-An update on patient populations with a wide range of cardiovascular risk.

   1. Böger, Rainer
   2. Maas, Renke
   3. Schulze, Friedrich
   4. Schwedhelm, Edzard

   2009 - Forschungsinformationssystem des UKE
6. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community.

   1. Böger, Rainer
   2. Sullivan Lisa, M
   3. Schwedhelm, Edzard
   4. Wang, Thomas J
   5. Maas, Renke
   6. Benjamin, Emelia J
   7. Schulze, Friedrich

   2009 - Forschungsinformationssystem des UKE
7. Asymmetric dimethylarginine reference intervals determined with liquid chromatography-tandem mass spectrometry: results from the Framingham offspring cohort.

   1. Schwedhelm, Edzard
   2. Xanthakis, Vanessa
   3. Maas, Renke
   4. Sullivan Lisa, M
   5. Schulze, Friedrich
   6. Riederer, Ulrich
   7. Benndorf, Ralf

   2009 - Forschungsinformationssystem des UKE
8. Association of the Endogenous Nitric Oxide Synthase Inhibitor ADMA With Carotid Artery Intimal Media Thickness in the Framingham Heart Study Offspring Cohort.

   1. Maas, Renke
   2. Xanthakis, Vanessa
   3. Polak, Joseph F
   4. Schwedhelm, Edzard
   5. Sullivan Lisa, M
   6. Benndorf, Ralf
   7. Schulze, Friedrich

   2009 - Forschungsinformationssystem des UKE
9. L-Arginine enhances the triglyceride-lowering effect of simvastatin in patients with elevated plasma triglycerides.

   1. Schulze, Friedrich
   2. Glos, Sabrina
   3. Petruschka, Dörte
   4. Altenburg, Christiane
   5. Maas, Renke
   6. Benndorf, Ralf
   7. Schwedhelm, Edzard

   2009 - Forschungsinformationssystem des UKE
10. Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's disease.

    1. Arlt, Sönke
    2. Schulze, Friedrich
    3. Eichenlaub, Martin
    4. Maas, Renke
    5. Lehmbeck, Jan
    6. Schwedhelm, Edzard
    7. Jahn, Holger

    2008 - Forschungsinformationssystem des UKE
11. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism.

    1. Schwedhelm, Edzard
    2. Maas, Renke
    3. Freese, Ralf
    4. Jung, Donald
    5. Lukacs, Zoltan
    6. Jambrecina, Alen
    7. Spickler, William

    2008 - Forschungsinformationssystem des UKE
12. A stable-isotope based technique for the determination of dimethylarginine dimethylaminohydrolase (DDAH) activity in mouse tissue.

    1. Maas, Renke
    2. Tan-Andreesen, Jing
    3. Schwedhelm, Edzard
    4. Schulze, Friedrich
    5. Böger, Rainer

    2007 - Forschungsinformationssystem des UKE
13. Pharmacokinetics of oral doses of telmisartan and nisoldipine, given alone and in combination, in patients with essential hypertension.

    1. Bajcetic, Milica
    2. Benndorf, Ralf
    3. Appel, Daniel
    4. Schwedhelm, Edzard
    5. Schulze, Friedrich
    6. Riekhof, Daniel
    7. Maas, Renke

    2007 - Forschungsinformationssystem des UKE
14. Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in der Region Augsburg study and experimental data.

    1. Maas, Renke
    2. Schulze, Friedrich
    3. Baumert, Jens
    4. Löwel, Hannelore
    5. Hamraz, Khatera
    6. Schwedhelm, Edzard
    7. Koenig, Wolfgang

    2007 - Forschungsinformationssystem des UKE
15. High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma.

    1. Schwedhelm, Edzard
    2. Maas, Renke
    3. Tan-Andresen, Jing
    4. Schulze, Friedrich
    5. Riederer, Ulrich
    6. Böger, Rainer

    2007 - Forschungsinformationssystem des UKE
16. Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections.

    1. Zoccali, Carmine
    2. Maas, Renke
    3. Cutrupi, Sebastiano
    4. Pizzini, Patrizia
    5. Finocchiaro, Piero
    6. Cambareri, Francesco
    7. Panuccio, Vincenzo

    2007 - Forschungsinformationssystem des UKE
17. Comparison of HPLC method and commercial ELISA assay for asymmetric dimethylarginine (ADMA) determination in human serum.

    1. Schulze, Friedrich
    2. Schwedhelm, Edzard
    3. Maas, Renke
    4. Böger, Rainer H

    2006 - Forschungsinformationssystem des UKE
18. Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension.

    1. Benndorf, Ralf A
    2. Rudolph, Tanja Katharina
    3. Appel, Daniel
    4. Schwedhelm, Edzard
    5. Maas, Renke
    6. Schulze, Friedrich
    7. Silberhorn, Elisabeth

    2006 - Forschungsinformationssystem des UKE
19. Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study.

    1. Schulze, Friedrich
    2. Lenzen, Henrike
    3. Hanefeld, Christoph
    4. Bartling, Asja
    5. Osterziel, Karl J
    6. Goudeva, Lilia
    7. Schmidt-Lucke, Caroline

    2006 - Forschungsinformationssystem des UKE
20. Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality.

    1. Böger, Rainer H
    2. Maas, Renke
    3. Schulze, Friedrich
    4. Schwedhelm, Edzard

    2005 - Forschungsinformationssystem des UKE